Neuromodulation clues in late-life depression and its impact on mood, thinking, and daily function
Official title: Neuromodulatory system abnormalities in late life depression: Associations with mood, cognition, and motor frailty
Funded at University of California, San Francisco · NIH-11357619 · Data updated 2026-11-12
This study looks at how brain chemical systems linked to mood and movement lie behind late-life depression and its effects on thinking and frailty in older adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | July 1, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $3,131,019 |
| NIH project number | 4RF1MH139950-02 |
| Project ID | NIH-11357619 on NIH RePORTER |
Who could benefit from this research
✓Could help
Older adults with Major Depressive Disorder or late-life depression, and individuals at risk for cognitive decline.
✕Less likely to help
Individuals without depression or neuromodulatory-related risks may not directly benefit from this study.
What this research studies
Researchers at UCSF will examine how changes in brainstem and basal forebrain networks related to mood and alertness contribute to depression, slower thinking, and physical frailty in older adults. The project uses imaging and clinical assessments to map neuromodulatory system abnormalities and their connections to mood, cognition, and motor function. By understanding these links, the team aims to identify early markers that predict risk of cognitive decline and functional loss in late-life depression. Participants may include older adults with or without depression, followed over time to observe how neuromodulatory changes relate to outcomes. The ultimate goal is to inform earlier interventions to improve mood, cognitive health, and daily functioning.
Why it matters
Potential benefit: Could lead to earlier detection of people at risk for cognitive decline and frailty, enabling timely interventions to improve mood and functioning.
How similar studies have gone: Previous research links neuromodulatory system changes to mood and cognitive outcomes, supporting potential relevance of this approach.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Mackin, Robert Scott — University of California, San Francisco
- Study coordinator: Mackin, Robert Scott
Related research
Other NIH-funded projects on the same topics.
-
Mood-state classifiers to guide brain stimulation for treatment-resistant bipolar depression
This project tests a brain stimulation therapy combined with wearable and smartphone data to help people with treatment-resistant bipolar depression regain mood stability.
-
Sex differences in how respiratory-gated tVNS affects brain, mood, and heart health in major depression
A study at a major hospital will test whether a breathing-linked ear nerve stimulation helps mood and brain signals differently for men and women with major depression.
-
Impact of prenatal immune dysregulation on brain networks related to mood in major depression
This project looks at how immune system changes before birth may influence brain networks tied to mood and mood disorders in adults.
-
Personalized cognitive profiles to guide depression care
Using short computer tasks and a smartphone app to create individualized thinking profiles for adults with depression so treatment can better match their needs.
-
Brain implants and wearables to monitor and help severe bipolar depression
This project uses an implanted brain stimulator together with phone and wearable data to detect mood patterns and help people whose bipolar depression hasn't responded to other treatments.
-
Improving personalized treatment for depression using cognitive assessments
This study is creating a friendly app that helps people with depression by tracking their behavior to better understand their needs and improve their treatment options.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.